Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients
ClinicalTrials.gov study NCT00907166. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma
ClinicalTrials.gov study NCT04812145. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients
ClinicalTrials.gov study NCT05947825. IPD Sharing: NO. Countries: 0. Publications: 0.
Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)
ClinicalTrials.gov study NCT04947059. IPD Sharing: YES. Countries: 1. Publications: 0.
Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients
ClinicalTrials.gov study NCT06234072. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01233375. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment
ClinicalTrials.gov study NCT05170438. IPD Sharing: NO. Countries: 1. Publications: 0.
Canagliflozin With Gemcitabine in Pancreatic Carcinoma
ClinicalTrials.gov study NCT05903703. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer
ClinicalTrials.gov study NCT01469598. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00176813. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00268411. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine in NK/T Cell Lymphoma
ClinicalTrials.gov study NCT01660568. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
ClinicalTrials.gov study NCT02128282. IPD Sharing: NO. Countries: 3. Publications: 0.
High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT03697239. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT03435289. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT00191256. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma
ClinicalTrials.gov study NCT05822453. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy
ClinicalTrials.gov study NCT00372944. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma
ClinicalTrials.gov study NCT01333124. IPD Sharing: NO. Countries: 1. Publications: 0.
Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer
ClinicalTrials.gov study NCT02558959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.